Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Metastatic Non-Small Cell Lung Carcinoma|Metastatic Colorectal Cancer|Metastatic Breast Cancer
Interventions: DIAGNOSTIC_TEST: Blood-based cell-free cfDNA qPCR assay
Sponsor: Cadex Genomics